对α-synuclein和纳米体之间的独特识别模块的结构见解
Zeyaul Islam1, Nishant N Vaikath2, Issam Hmila2
1Diabetes Center, Qatar Biomedical Research Institute, Hamad Bin Khalifa University, Qatar Foundation, Doha, Qatar.
Protein science : a publication of the Protein Society
|December 18, 2023
概括
研究人员揭示了一种新的纳米体结合机制,用于α-synuclein (αSyn),这是一种与帕金森病相关的蛋白质. 这一发现使得基于结构的工程能够改善纳米体诊断和治疗.
科学领域:
- 结构生物学 结构生物学
- 蛋白质工程是指蛋白质工程.
- 神经科学是一个神经科学.
背景情况:
- 纳米体是具有生物应用独特特性的抗体碎片.
- α-synuclein (αSyn) 聚合是帕金森病的一个标志.
- 了解蛋白质-纳米体相互作用对于开发向疗法至关重要.
研究的目的:
- 为了阐明纳米体Nbα-syn01与αSyn结合的晶体结构.
- 为了研究这种独特的纳米体-αSyn相互作用的分子基础.
- 探索纳米体的结构引导工程,以提高治疗潜力.
主要方法:
- 用X射线晶体学来确定Nbα-syn01和αSyn的复杂结构.
- 结构引导的Nbα-syn01.01的截断.
- 结合亲和度测试和α-synuclein聚合抑制研究.
主要成果:
- 晶体结构揭示了一个独特的结合模式,其中αSyn替代了纳米体的N-终端区域.
- 识别主要通过主链相互作用进行介导,在中央αSyn区域 (48-52) 具有特异性.
- 结构引导的截断导致了更紧密的结合,并改善了α-synuclein聚合的抑制.
结论:
- 这项研究揭示了α-synuclein的新型纳米体识别机制.
- 这为增强的结合亲和力提供了一个分子解释.
- 这些发现为工程纳米体提供了一个框架,作为改善帕金森病的诊断和治疗工具.
更多相关视频
12:58Characterizing Individual Protein Aggregates by Infrared Nanospectroscopy and Atomic Force Microscopy
Published on: September 12, 2019
9.8K
07:56Utilizing Time-Resolved Protein-Induced Fluorescence Enhancement to Identify Stable Local Conformations One α-Synuclein Monomer at a Time
Published on: May 30, 2021
3.2K
相关概念视频
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...